Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Freiburg University

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. Aging Knowl. Environ., 2 July 2003
Vol. 2003, Issue 26, p. pe18
[DOI: 10.1126/sageke.2003.26.pe18]

PERSPECTIVES

The Future of Human Longevity--How Important Are Markets and Innovation?

The is a reprinting of testimony given before the United States Senate Special Committee on Aging (3 June 2003).

James W. Vaupel

The author is at the Max Planck Institute for Demographic Research, Rostock, Germany, and the Terry Sanford Institute of Public Policy at Duke University, Durham, NC 27708, USA. E-mail: JWV{at}demogr.mpg.de

http://sageke.sciencemag.org/cgi/content/full/sageke;2003/26/pe18

Key Words: demography • Social Security Administration • human life expectancy • mortality

Abstract: In a hearing before the United States Senate Special Committee on Aging, a well-respected demographer warns that there is no evidence of slowing in the long-term rise in best-practice life expectancy in developed countries. The author discusses how these findings will affect the future of Social Security and argues for a larger, more focused effort with respect to longevity research by demographers, epidemiologists, and economists.

Citation: J. W. Vaupel, The Future of Human Longevity--How Important Are Markets and Innovation? Sci. SAGE KE 2003, pe18 (2 July 2003)
http://sageke.sciencemag.org/cgi/content/full/sageke;2003/26/pe18

Read the Full Text







ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products